DURAMORPH PF Drug Patent Profile
✉ Email this page to a colleague
When do Duramorph Pf patents expire, and when can generic versions of Duramorph Pf launch?
Duramorph Pf is a drug marketed by Hikma and is included in one NDA.
The generic ingredient in DURAMORPH PF is morphine sulfate. There are twenty-three drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the morphine sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Duramorph Pf
A generic version of DURAMORPH PF was approved as morphine sulfate by HOSPIRA on May 11th, 1988.
Summary for DURAMORPH PF
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 38 |
| Clinical Trials: | 34 |
| Patent Applications: | 3,492 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | DURAMORPH PF at DailyMed |
Recent Clinical Trials for DURAMORPH PF
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Indiana University | Phase 1/Phase 2 |
| Washington University School of Medicine | Phase 2 |
| The Foundation for Barnes-Jewish Hospital | Phase 2 |
Pharmacology for DURAMORPH PF
| Drug Class | Opioid Agonist |
| Mechanism of Action | Full Opioid Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for DURAMORPH PF
US Patents and Regulatory Information for DURAMORPH PF
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hikma | DURAMORPH PF | morphine sulfate | INJECTABLE;INJECTION | 018565-001 | Sep 18, 1984 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Hikma | DURAMORPH PF | morphine sulfate | INJECTABLE;INJECTION | 018565-002 | Sep 18, 1984 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
